Abstract: The present invention relates to compounds of with a base structure of formula 1
The compounds of formula I are shown to have activity as metabotropic glutamate receptor antagonists.
Type:
Grant
Filed:
October 13, 2000
Date of Patent:
June 18, 2002
Assignee:
Hoffmann-la Roche Inc.
Inventors:
Geo Adam, Alexander Alanine, Erwin Goetschi, Vincent Mutel, Thomas Johannes Woltering